Powered by

Creative Medical Technology Holdings Files Patent on AmnioStem Stroke Therapy

Dec 13, 2016 - PR Newswire

�Creative Medical Technology Holdings (the "Company") (OTCQB:CELZ) announced today filing of US patent application #62/400557 entitled "Treatment of Stroke by Amniotic Fluid Derived Stem Cell Conditioned Media and Products Derived Thereof."

The patent application covers the use of the Company's newly licensed AmnioStem stem cell as a production means for generation of nanoparticles termed "exosomes," which regenerate damaged brain tissue after stroke.� The AmnioStem stem cell is subjec...